Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Para-sternal block and postoperative respiratory function after cardiac sternotomy
2022-000833-18Phase 3Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in respiratory complication and respiratory failure (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Postoperative respiratory function. Started Mar 2022; status: active.
02
Drugs
ropivacaine
03
Conditions
respiratory complicationrespiratory failure
Beyond the preview
Go deeper on 2022-000833-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000833-18.